David T. Brown is an accomplished leader in market access and patient services within the pharmaceutical industry, currently serving as the Vice President and Head of US Market Access and Patient Services at Galderma since August 2021. With a strong background in strategic planning and team-building, David has developed and implemented successful market access strategies for various products, including Nemolizumab. Prior to Galderma, David held key positions at Takeda and Shire, where responsibilities included leading market access strategies for rare diseases and overseeing payer marketing initiatives. David began the career in healthcare at Maxim Healthcare Services, advancing from a recruiter to branch manager. Educational qualifications include an M.B.A. from Dowling College and a Bachelor's degree in Business Management from Roger Williams University.
This person is not in any teams
This person is not in any offices